Top experts by indication / Oncology
Most active experts in Leukemia, Myeloid, Acute
2026 edition, data as of October 26, 2026
303 key opinion leaders in the directory are tagged to Leukemia, Myeloid, Acute. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 301 of the 303 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 21 trials |
| 2 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 17 trials |
| 3 | Tapan KadiaThe University of Texas MD Anderson Cancer Center, TX | 15 trials |
| 4 | Courtney DiNardoThe University of Texas MD Anderson Cancer Center, TX | 14 trials |
| 5 | Olatoyosi OdenikeUniversity of Chicago, IL | 14 trials |
| 6 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 13 trials |
| 7 | Gautam BorthakurThe University of Texas MD Anderson Cancer Center, TX | 12 trials |
| 8 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 12 trials |
| 9 | Geoffrey UyWashington University School of Medicine, MO | 12 trials |
| 10 | Naval DaverThe University of Texas MD Anderson Cancer Center, TX | 12 trials |
| 11 | Timothy PardeeAtrium Health Wake Forest Baptist, NC | 11 trials |
| 12 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 10 trials |
| 13 | Brian JonasUniversity of California, Davis, CA | 10 trials |
| 14 | Jessica AltmanNorthwestern University Feinberg School of Medicine, IL | 10 trials |
| 15 | Amir FathiMA | 9 trials |
| 16 | Anthony SteinCity of Hope, CA | 9 trials |
| 17 | Ryotaro NakamuraCity of Hope, CA | 9 trials |
| 18 | Roland WalterFred Hutchinson Cancer Center, WA | 9 trials |
| 19 | Joshua ZeidnerUniversity of North Carolina at Chapel Hill, NC | 9 trials |
| 20 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 21 | Jeffrey RubnitzSt. Jude Children's Research Hospital, TN | 8 trials |
| 22 | Judith KarpJohns Hopkins University School of Medicine, MD | 8 trials |
| 23 | Gary SchillerUniversity of California, Los Angeles, CA | 8 trials |
| 24 | Richard StoneDana-Farber Cancer Institute, MA | 8 trials |
| 25 | John DipersioWashington University School of Medicine, MO | 8 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 117 of the 303 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 270,473 citations |
| 2 | Scott SolomonBrigham and Women's Hospital, MA | 187,732 citations |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 144,714 citations |
| 4 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 5 | Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, TX | 90,546 citations |
| 6 | Martin TallmanNorthwestern University Feinberg School of Medicine, IL | 89,799 citations |
| 7 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 8 | Richard StoneDana-Farber Cancer Institute, MA | 77,206 citations |
| 9 | Marina KonoplevaAlbert Einstein College of Medicine | 71,749 citations |
| 10 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 71,079 citations |
| 11 | Stephan GruppChildren's Hospital of Philadelphia, PA | 64,125 citations |
| 12 | Francis GilesTX | 60,986 citations |
| 13 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 14 | Guido MarcucciCity of Hope, CA | 54,499 citations |
| 15 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
| 16 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 50,317 citations |
| 17 | Courtney DiNardoThe University of Texas MD Anderson Cancer Center, TX | 49,719 citations |
| 18 | Mark LitzowMayo Clinic, MN | 48,382 citations |
| 19 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 48,319 citations |
| 20 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 47,488 citations |
| 21 | Daniel DeangeloDana-Farber Cancer Institute, MA | 38,550 citations |
| 22 | Philippe ArmandMayo Clinic, MN | 38,160 citations |
| 23 | Stefan FaderlJazz Pharmaceuticals, NJ | 38,127 citations |
| 24 | Mikkael SekeresSylvester Comprehensive Cancer Center, FL | 37,894 citations |
| 25 | Gautam BorthakurThe University of Texas MD Anderson Cancer Center, TX | 37,749 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 81 of the 303 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Hans-Peter KiemWA | 31 awards |
| 2 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 3 | Roland WalterFred Hutchinson Cancer Center, WA | 14 awards |
| 4 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 13 awards |
| 5 | Marina KonoplevaAlbert Einstein College of Medicine | 12 awards |
| 6 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 7 | Stephan GruppChildren's Hospital of Philadelphia, PA | 9 awards |
| 8 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 9 | Richard AplencChildren's Hospital of Philadelphia, PA | 8 awards |
| 10 | Steven GoreMD | 8 awards |
| 11 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 12 | Guido MarcucciCity of Hope, CA | 8 awards |
| 13 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 14 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 15 | Joanne KurtzbergDuke University Medical Center, NC | 7 awards |
| 16 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 6 awards |
| 17 | Michael PulsipherCA | 6 awards |
| 18 | Marie BleakleySeattle Children's Hospital, WA | 5 awards |
| 19 | Colleen DelaneyWA | 5 awards |
| 20 | Gregory YanikUniversity of Michigan, MI | 5 awards |
| 21 | Jean-Pierre IssaPA | 5 awards |
| 22 | Paul ShamiHuntsman Cancer Institute, University of Utah, UT | 5 awards |
| 23 | Timothy PardeeAtrium Health Wake Forest Baptist, NC | 5 awards |
| 24 | Hillard LazarusCase Western Reserve University School of Medicine, OH | 5 awards |
| 25 | Scott SolomonBrigham and Women's Hospital, MA | 5 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 52 of the 303 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Hagop KantarjianThe University of Texas MD Anderson Cancer Center, TX | 859 contributions |
| 2 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 677 contributions |
| 3 | Jorge CortesUniversity of Alabama at Birmingham (UAB), AL | 654 contributions |
| 4 | Ghayas IssaThe University of Texas MD Anderson Cancer Center, TX | 275 contributions |
| 5 | Richard StoneDana-Farber Cancer Institute, MA | 242 contributions |
| 6 | Guido MarcucciCity of Hope, CA | 240 contributions |
| 7 | Daniel DeangeloDana-Farber Cancer Institute, MA | 229 contributions |
| 8 | Eunice WangRoswell Park Comprehensive Cancer Center, NY | 222 contributions |
| 9 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 10 | Eric PadronUniversity of South Florida (USF Health), FL | 217 contributions |
| 11 | Wendy StockUniversity of Chicago, IL | 210 contributions |
| 12 | Gail RobozWeill Cornell Medicine, NY | 208 contributions |
| 13 | Gary SchillerUniversity of California, Los Angeles, CA | 193 contributions |
| 14 | Ravi VijWashington University School of Medicine in St. Louis, MO | 184 contributions |
| 15 | Maria BaerUniversity of Maryland School of Medicine, MD | 180 contributions |
| 16 | Anthony SteinCity of Hope, CA | 171 contributions |
| 17 | John DipersioWashington University School of Medicine, MO | 171 contributions |
| 18 | Roland WalterFred Hutchinson Cancer Center, WA | 135 contributions |
| 19 | Geoffrey UyWashington University School of Medicine, MO | 130 contributions |
| 20 | Daniel PollyeaUniversity of Colorado School of Medicine, CO | 128 contributions |
| 21 | David MaloneyFred Hutchinson Cancer Center, WA | 127 contributions |
| 22 | Ryotaro NakamuraCity of Hope, CA | 125 contributions |
| 23 | Vinod PullarkatCity of Hope, CA | 112 contributions |
| 24 | Philippe ArmandMayo Clinic, MN | 111 contributions |
| 25 | Stephan GruppChildren's Hospital of Philadelphia, PA | 108 contributions |
Emerging
12 of the 303 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Rafael BejarUniversity of California, San Diego, CA |
| Uma BorateThe Ohio State University, OH |
| Phillip GarfinJazz Pharmaceuticals, CA |
| Tanja GruberStanford University School of Medicine, CA |
| Malika KapadiaBoston Children's Hospital, MA |
| Christine McMahonUniversity of Colorado Anschutz, CO |
| Yael MosseChildren's Hospital of Philadelphia, PA |
| Bilal OmerBaylor College of Medicine, TX |
| Azra RazaColumbia University Irving Medical Center, NY |
| Jacalyn RosenblattBeth Israel Deaconess Medical Center, MA |
| Dan VoglUniversity of Pennsylvania, PA |
| Joshua ZeidnerUniversity of North Carolina at Chapel Hill, NC |
How these tables are computed
The cohort is every profile in the directory tagged to Leukemia, Myeloid, Acute, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Leukemia, Myeloid, Acute profile in the directory